Bayer AG
BAYRY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,546,000 | -$2,941,000 | $4,166,000 | $1,022,000 |
| Dep. & Amort. | $8,783,000 | $3,933,000 | $6,503,000 | $3,056,000 |
| Deferred Tax | $0 | $0 | -$2,067,000 | -$602,000 |
| Stock-Based Comp. | $0 | $0 | $365,000 | $238,000 |
| Change in WC | $85,000 | -$4,065,000 | -$2,696,000 | $1,056,000 |
| Other Non-Cash | $1,046,000 | $8,190,000 | $822,000 | $319,000 |
| Operating Cash Flow | $7,368,000 | $5,117,000 | $7,093,000 | $5,089,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,778,000 | -$2,751,000 | -$2,949,000 | -$2,611,000 |
| Net Acquisitions | -$167,000 | -$493,000 | $2,198,000 | -$1,346,000 |
| Inv. Purchases | -$251,000 | -$445,000 | -$3,010,000 | -$400,000 |
| Inv. Sales/Matur. | $2,576,000 | $139,000 | $32,000 | $4,702,000 |
| Other Inv. Act. | $784,000 | -$464,000 | $1,348,000 | $510,000 |
| Investing Cash Flow | $164,000 | -$4,014,000 | -$2,381,000 | $855,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5,018,000 | $3,253,000 | -$974,000 | -$2,452,000 |
| Stock Issued | $0 | $23,000 | $15,000 | $0 |
| Stock Repurch. | -$16,000 | -$24,000 | $0 | $0 |
| Dividends Paid | -$131,000 | -$2,379,000 | -$1,965,000 | -$1,963,000 |
| Other Fin. Act. | -$2,013,000 | -$1,552,000 | -$1,276,000 | -$1,200,000 |
| Financing Cash Flow | -$7,178,000 | -$679,000 | -$4,220,000 | -$5,645,000 |
| Forex Effect | -$68,000 | -$185,000 | $112,000 | $35,000 |
| Net Chg. in Cash | $284,000 | $736,000 | $607,000 | $373,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,907,000 | $5,171,000 | $4,564,000 | $4,191,000 |
| End Cash | $6,191,000 | $5,907,000 | $5,171,000 | $4,564,000 |
| Free Cash Flow | $4,590,000 | $2,366,000 | $4,144,000 | $2,478,000 |